Mecanismos moleculares asociados al síndrome metabólico
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (10)
2023
-
Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ
Biomedicine and Pharmacotherapy, Vol. 167
2016
2009
-
β-cell hyperplasia induced by hepatic insulin resistance: Role of a liver-pancreas endocrine axis through insulin receptor A isoform
Diabetes, Vol. 58, Núm. 4, pp. 820-828
2004
-
IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes
Hepatology, Vol. 40, Núm. 6, pp. 1285-1294
2003
-
Essential role of protein kinase Cζ in the impairment of insulin-induced glucose transport in IRS-2-deficient brown adipocytes
FEBS Letters, Vol. 536, Núm. 1-3, pp. 161-166
-
Insulin-induced up-regulated uncoupling protein-1 expression is mediated by insulin receptor substrate 1 through the phosphatidylinositol 3-kinase/Akt signaling pathway in fetal brown adipocytes
Journal of Biological Chemistry, Vol. 278, Núm. 12, pp. 10221-10231
-
Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes
Diabetes, Vol. 52, Núm. 9, pp. 2239-2248
2002
-
Increased insulin sensitivity in IGF-I receptor-deficient brown adipocytes
Diabetes, Vol. 51, Núm. 3, pp. 743-754
1999
-
Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: Requirement of IRS-1 for lipid synthesis
Diabetes, Vol. 48, Núm. 11, pp. 2122-2131